TN SB1420 | 2017-2018 | 110th General Assembly
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 9 2017 - 25% progression, died in committee
Action: 2017-02-13 - Passed on Second Consideration, refer to Senate Commerce and Labor Committee
Pending: Senate Commerce and Labor Committee
Text: Latest bill text (Draft #1) [PDF]
Status: Introduced on February 9 2017 - 25% progression, died in committee
Action: 2017-02-13 - Passed on Second Consideration, refer to Senate Commerce and Labor Committee
Pending: Senate Commerce and Labor Committee
Text: Latest bill text (Draft #1) [PDF]
Summary
As introduced, enacts the Prescription Drug Fair Pricing Act; requires studies and reports on or before January 15, 2018, by the commissioner of health concerning price gouging for essential generic drugs and the commissioner of commerce and insurance concerning price transparency for prescription drugs; requires reports to legislative committees. - Amends TCA Title 4; Title 53; Title 56; Title 63; Title 68 and Title 71.
Title
As introduced, enacts the Prescription Drug Fair Pricing Act; requires studies and reports on or before January 15, 2018, by the commissioner of health concerning price gouging for essential generic drugs and the commissioner of commerce and insurance concerning price transparency for prescription drugs; requires reports to legislative committees. - Amends TCA Title 4; Title 53; Title 56; Title 63; Title 68 and Title 71.
Sponsors
| Sen. Lee Harris [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2017-02-13 | Senate | Passed on Second Consideration, refer to Senate Commerce and Labor Committee |
| 2017-02-09 | Senate | Introduced, Passed on First Consideration |
| 2017-02-09 | Senate | Filed for introduction |
Same As/Similar To
HB1328 (Crossfiled) 2017-02-17 - Assigned to s/c Insurance and Banking Subcommittee
